Vaccination against herpes zoster (shingles) with the adjuvant inactivated vaccine will in future be compulsory for all persons aged 60 and over, according to the Joint Federal Committee (GBA). The same applies to persons aged 50 and over with increased health risks such as rheumatism, COPD, asthma, chronic inflammatory bowel disease, diabetes, renal insufficiency or HIV infection.